Document ID: FDA-2010-N-0534-0003
Agency: fda
Document Type: Rule
Title: New Animal Drugs for Minor Use and Minor Species; Confirmation of Effective Date
Posted Date: 2011-03-02T05:00Z

[Federal Register Volume 76, Number 41 (Wednesday, March 2, 2011)]
[Rules and Regulations]
[Pages 11331-11332]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-4593]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 516

[Docket No. FDA-2010-N-0534]
RIN 0910-AG58

New Animal Drugs for Minor Use and Minor Species; Confirmation of 
Effective Date

AGENCY: Food and Drug Administration, HHS.

ACTION: Direct final rule; confirmation of effective date.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is confirming the 
effective date of March 30, 2011, for the final rule that appeared in 
the Federal Register of November 15, 2010 (75 FR 69586). The direct 
final rule amends the regulations regarding new animal drugs for minor 
use and minor species (MUMS) to update language and clarify the intent 
of the regulations consistent with the preambles to the proposed and 
final rules. This document confirms the effective date of the direct 
final rule.

DATES: Effective date confirmed: March 30, 2011.

FOR FURTHER INFORMATION CONTACT:  Meg Oeller, Center for Veterinary 
Medicine (HFV-50), Food and Drug Administration, 7500 Standish Pl., 
Rockville, MD 20855, 240-276-9005, e-mail: margaret.oeller@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: In the Federal Register of November 15, 2010 
(75 FR 69586), FDA solicited comments concerning the direct final rule 
for a 75-day period ending January 31, 2011. FDA stated that the 
effective date of the

[[Page 11332]]

direct final rule would be on March 30, 2011, 60 days after the end of 
the comment period, unless any significant adverse comment was 
submitted to FDA during the comment period. FDA did not receive any 
significant adverse comments.

    Authority:  21 U.S.C. 360ccc-1, 360ccc-2, 371. Accordingly, the 
amendments issued thereby are effective.

    Dated: February 24, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-4593 Filed 3-1-11; 8:45 am]
BILLING CODE 4160-01-P